Fig. 2From: Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomyKaplan-Meier curve of PSA half-life groups for CRPC stratified by Gleason score. a Gleason ≤7 stratum b Gleason >7 stratumBack to article page